@article{CDT13726,
author = {Luis Ortega-Paz and Salvatore Brugaletta and Hector M. Garcia-Garcia and Manel Sabaté},
title = {Bioresorbable scaffolds: should we stay simple or go complex?},
journal = {Cardiovascular Diagnosis and Therapy},
volume = {7},
number = {3},
year = {2017},
keywords = {},
abstract = {From its inception, scaffolding the coronary artery with bioresorbable scaffolds (BRS) has been projected as the fourth revolution in interventional cardiology, primarily designed to overcome drug-eluting stents (DES) limitations (1). This technology aims at proving some presumptive advantages over DES such as: restoration of coronary physiology and vascular adaptive responses; to obtain late lumen gain and plaque regression; and to decrease late and very-late events (1).},
issn = {2223-3660}, url = {https://cdt.amegroups.org/article/view/13726}
}